RATIONALE: Asthma is prospectively associated with age-related chronic diseases and mortality, suggesting the hypothesis that asthma may relate to a general, multisystem phenotype of accelerated aging. OBJECTIVES: To test whether chronic asthma is associated with a proposed biomarker of accelerated aging, leukocyte telomere length. METHODS: Asthma was ascertained prospectively in the Dunedin Multidisciplinary Health and Development Study cohort (n = 1,037) at nine in-person assessments spanning ages 9-38 years. Leukocyte telomere length was measured at ages 26 and 38 years. Asthma was classified as life-course-persistent, childhood-onset not meeting criteria for persistence, and adolescent/adult-onset. We tested associations between asthma and leukocyte telomere length using regression models. We tested for confounding of asthma-leukocyte telomere length associations using covariate adjustment. We tested serum C-reactive protein and white blood cell counts as potential mediators of asthma-leukocyte telomere length associations. MEASUREMENTS AND MAIN RESULTS: Study members with life-course-persistent asthma had shorter leukocyte telomere length as compared with sex- and age-matched peers with no reported asthma. In contrast, leukocyte telomere length in study members with childhood-onset and adolescent/adult-onset asthma was not different from leukocyte telomere length in peers with no reported asthma. Adjustment for life histories of obesity and smoking did not change results. Study members with life-course-persistent asthma had elevated blood eosinophil counts. Blood eosinophil count mediated 29% of the life-course-persistent asthma-leukocyte telomere length association. CONCLUSIONS: Life-course-persistent asthma is related to a proposed biomarker of accelerated aging, possibly via systemic eosinophilic inflammation. Life histories of asthma can inform studies of aging.
RATIONALE: Asthma is prospectively associated with age-related chronic diseases and mortality, suggesting the hypothesis that asthma may relate to a general, multisystem phenotype of accelerated aging. OBJECTIVES: To test whether chronic asthma is associated with a proposed biomarker of accelerated aging, leukocyte telomere length. METHODS: Asthma was ascertained prospectively in the Dunedin Multidisciplinary Health and Development Study cohort (n = 1,037) at nine in-person assessments spanning ages 9-38 years. Leukocyte telomere length was measured at ages 26 and 38 years. Asthma was classified as life-course-persistent, childhood-onset not meeting criteria for persistence, and adolescent/adult-onset. We tested associations between asthma and leukocyte telomere length using regression models. We tested for confounding of asthma-leukocyte telomere length associations using covariate adjustment. We tested serum C-reactive protein and white blood cell counts as potential mediators of asthma-leukocyte telomere length associations. MEASUREMENTS AND MAIN RESULTS: Study members with life-course-persistent asthma had shorter leukocyte telomere length as compared with sex- and age-matched peers with no reported asthma. In contrast, leukocyte telomere length in study members with childhood-onset and adolescent/adult-onset asthma was not different from leukocyte telomere length in peers with no reported asthma. Adjustment for life histories of obesity and smoking did not change results. Study members with life-course-persistent asthma had elevated blood eosinophil counts. Blood eosinophil count mediated 29% of the life-course-persistent asthma-leukocyte telomere length association. CONCLUSIONS: Life-course-persistent asthma is related to a proposed biomarker of accelerated aging, possibly via systemic eosinophilic inflammation. Life histories of asthma can inform studies of aging.
Authors: Patrick W Sullivan; Vahram H Ghushchyan; Julia F Slejko; Vasily Belozeroff; Denise R Globe; Shao-Lee Lin Journal: J Allergy Clin Immunol Date: 2011-02 Impact factor: 10.793
Authors: Sarah L Appleton; Robert J Adams; David H Wilson; Anne W Taylor; Richard E Ruffin Journal: J Allergy Clin Immunol Date: 2006-11-07 Impact factor: 10.793
Authors: Tony Robertson; G David Batty; Geoff Der; Candida Fenton; Paul G Shiels; Michaela Benzeval Journal: Epidemiol Rev Date: 2012-12-20 Impact factor: 6.222
Authors: Dru D Claar; Emma K Larkin; Lisa Bastarache; Timothy S Blackwell; James E Loyd; Tina V Hartert; Joshua C Denny; Jonathan A Kropski Journal: Am J Respir Crit Care Med Date: 2016-01-01 Impact factor: 21.405
Authors: Samuel J Ridout; Kathryn K Ridout; Hung-Teh Kao; Linda L Carpenter; Noah S Philip; Audrey R Tyrka; Lawrence H Price Journal: Adv Psychosom Med Date: 2015-03-30
Authors: William Murray Thomson; Jiaxu Zeng; Jonathan M Broadbent; Lyndie A Foster Page; Idan Shalev; Terrie E Moffitt; Avshalom Caspi; Sheila M Williams; Antony W Braithwaite; Stephen P Robertson; Richie Poulton Journal: J Clin Periodontol Date: 2016-02-19 Impact factor: 8.728
Authors: Sofia Pavanello; Mariarita Stendardo; Giuseppe Mastrangelo; Melissa Bonci; Barbara Bottazzi; Manuela Campisi; Marco Nardini; Roberto Leone; Alberto Mantovani; Piera Boschetto Journal: Front Immunol Date: 2017-05-09 Impact factor: 7.561
Authors: Florencia M Barbé-Tuana; Lucas K Grun; Vinícius Pierdoná; Mariana M Parisi; Frederico Friedrich; Fátima T C R Guma; Leonardo A Pinto; Renato T Stein; Paulo M C Pitrez; Marcus H Jones Journal: Aging (Albany NY) Date: 2021-01-20 Impact factor: 5.682
Authors: Keith T S Tung; Rosa S Wong; Hing-Wai Tsang; Gilbert T Chua; Dicky Chan; Kate C Chan; Wilfred H S Wong; Jason C Yam; Marco Ho; Clement C Tham; Ian C K Wong; Godfrey C F Chan; Patrick Ip Journal: Genes (Basel) Date: 2021-05-18 Impact factor: 4.096